John M. Evans

Companies

• Beam TherapeuticsBoard member Feb 5, 2020 to now¹
• Beam TherapeuticsChief executive officer Feb 5, 2020 to now¹
• Verve Therapeutics, Inc.Board member Jun 16, 2021 to Jun 13, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Beam Therapeutics BEAM1,150,205 shares³$27.6M at $24.00Jul 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 30, 2026Sold 1,900 shares at $34.84 of Beam Therapeutics³
• Jun 30, 2026Sold 23,100 shares at $34.26 of Beam Therapeutics³
• Jun 30, 2026Exercised options 25,000 shares at $1.03 of Beam Therapeutics³
• Jun 29, 2026Sold 11,579 shares at $35.91 of Beam Therapeutics³
• Jun 29, 2026Sold 13,421 shares at $35.13 of Beam Therapeutics³
• Jun 29, 2026Exercised options 6,337 shares at $1.03 of Beam Therapeutics³
• Jun 29, 2026Exercised options 18,663 shares at $0.67 of Beam Therapeutics³
• Apr 1, 2026Sold 30,078 shares at $24.58 of Beam Therapeutics⁴
• Mar 31, 2026Granted 90,000 shares of Beam Therapeutics⁵
• Mar 31, 2026Sold 25,000 shares at $22.76 of Beam Therapeutics⁵
• Mar 31, 2026Exercised options 25,000 shares at $0.67 of Beam Therapeutics⁵
• Mar 30, 2026Sold 25,000 shares at $22.37 of Beam Therapeutics⁵
• Mar 30, 2026Exercised options 25,000 shares at $0.67 of Beam Therapeutics⁵
• Jan 30, 2026Sold 2,906 shares at $29.00 of Beam Therapeutics⁶
• Jan 30, 2026Sold 22,094 shares at $28.27 of Beam Therapeutics⁶
• Jan 30, 2026Exercised options 25,000 shares at $0.67 of Beam Therapeutics⁶
• Jan 29, 2026Sold 8,667 shares at $29.74 of Beam Therapeutics⁶
• Jan 29, 2026Sold 16,333 shares at $29.19 of Beam Therapeutics⁶
• Jan 29, 2026Exercised options 5,664 shares at $0.67 of Beam Therapeutics⁶
• Jan 29, 2026Exercised options 19,336 shares at $0.67 of Beam Therapeutics⁶
• Oct 2, 2025Sold 25,000 shares at $24.63 of Beam Therapeutics⁷
• Oct 2, 2025Exercised options 25,000 shares at $0.67 of Beam Therapeutics⁷
• Oct 1, 2025Sold 25,000 shares at $24.51 of Beam Therapeutics⁷
• Oct 1, 2025Exercised options 25,000 shares at $0.67 of Beam Therapeutics⁷
• Apr 1, 2025Sold 30,663 shares at $18.35 of Beam Therapeutics⁸